SETD1A and breast carcinoma: In addition, consistent with our findings in primary breast cancers, we also found that other HMTs, such as WHSC1L1, SUV420H1, and SETD1A, were commonly gained or amplified, and SETDB2 was commonly lost or deleted in breast cancer cell lines (Supplementary Figure S2).